Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2039 of 6351
-
Could a simple amino acid ease a devastating lung condition?
Disease control CompletedThe purpose of this study is to determine the safety and tolerance of an oral administration of methionine in the treatment of pulmonary alveolar proteinosis due to the double mutation Ala393Thr / Ser567Leu in the MARS gene. This disease is very severe and especially leads to chr…
Phase 1/2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Can botox ease leg stiffness after stroke? new trial investigates
Symptom relief OngoingThe purpose of this study is to determine whether a single treatment with administration of 400 Units NT 201 (botulinum toxin) is superior to placebo (no medicine) for the treatment of lower limb spasticity caused by stroke or traumatic brain injury (Main Period). Participants wi…
Phase 3 • Sponsor: Merz Pharmaceuticals GmbH • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
New hope for rare sarcoma? drug combo tested in 44 patients
Disease control CompletedThe yearly incidence of soft-tissue sarcomas (STS) in the USA is roughly 11,280 cases, and metastatic STS have a median overall survival of about 12 months. Sarcomas of the soft tissue are a heterogeneous group of malignant tumors of mesenchymal origin that originate in connectiv…
Phase 1/2 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Blood biomarkers may spot ectopic pregnancies early
Diagnosis CompletedEctopic pregnancy (EP) is a pathology that affects 3%-16% of pregnancies in humans, being the main cause of morbidity and maternal mortality in the first trimester of pregnancy worldwide. The relevance of this problem has led to a demand on the scientific community, to obtain spe…
Sponsor: Vida Recoletas Sevilla • Aim: Diagnosis
Last updated Jun 27, 2026 08:10 UTC
-
Personalized nutrition may stop weight gain after spinal injury
Prevention CompletedThis is a randomized clinical controlled trial (RCT) to investigate the impact of a personalized nutritional intervention on functional and clinical outcomes the first year after traumatic spinal cord injury. The long term goal is to prevent gain of body fat mass and obesity.
Sponsor: Sunnaas Rehabilitation Hospital • Aim: Prevention
Last updated Jun 27, 2026 14:00 UTC
-
New drug combo shows promise for Tough-to-Treat lymphomas
Disease control CompletedThis phase I trial studies the side effects and best dose of olaparib when given together with high-dose chemotherapy in treating patients with lymphomas that have come back or does not treatment and are undergoing stem cell transplant. Drugs used in chemotherapy, such as olapari…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New hope for Hard-to-Treat colorectal cancer: drug cocktail trial launches
Disease control OngoingCOLUMBIA-1 is a Phase 1b/2 platform study to evaluate the safety and efficacy of standard of care (FOLFOX plus bevacizumab) alone and in combination with novel oncology therapies in first-line metastatic microsatellite-stable colorectal cancer (MSS-CRC).
Phase 1/2 • Sponsor: MedImmune LLC • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Transplant Patients' vaccine shield under the microscope
Knowledge-focused Recruiting nowTransplantation is one of the most challenging and complex areas of modern medicine. Besides the intrinsic complexity of the surgical and medical procedures, transplantation medicine must take into account a flawless medical management before and after transplant, especially beca…
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Can we predict dangerous side effects when combining radiation and immunotherapy?
Knowledge-focused Recruiting nowEvery year, new molecular agents enter the market with more and more patients receiving these treatments, especially in the metastatic setting. These molecular agents could correspond to immunotherapy and modulators of signaling pathways. More than 50% of cancer patients will rec…
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
New pill aimed at Hard-to-Treat lung cancer shows early promise
Disease control OngoingThis is a prospective one-arm, two-stage phase 2 trial of TVB-2640 in KRAS mutant NSCLC patients. 13 patients will be treated with a minimum of 1 cycle of TVB-2640 therapy over 8 weeks.
Phase 2 • Sponsor: David E Gerber • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Zapping just a few spots: new hope for patients with worsening metastatic cancer?
Disease control OngoingSystemic therapy is the main treatment for patients with metastatic cancers. Oligo-progression has become a recognized entity for metastatic cancer and it is thought that a subset of cancer cells may develop heterogeneity and resistant clones while receiving systemic therapy. Thi…
Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New machine may help 'Marginal' donor livers work better after transplant
Disease control CompletedGiven the scarce donor supply, an increasing number of so-called marginal or extended criteria donor (ECD) organs have been used for liver transplantation. These ECD liver grafts are, however, known to be associated with a higher rate of early allograft dysfunction (EAD) and prim…
Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New Lung-Clearing device could ease breathing for kids with cystic fibrosis
Symptom relief CompletedChest physiotherapy plays a crucial role in treatment of lung disease in cystic fibrosis (CF). New airway clearance techniques (ACTs) adapted to individual needs are still being sought to achieve the best effect of airway clearance. The primary aim of this study is to assess the …
Sponsor: Physio-Assist • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Stem cell combo shows promise for Parkinson's in small trial
Disease control CompletedAn experimental study will be conducted at Iffat Anwar medical complex conducted to evaluate the effectiveness of PRP and stem Cell therapy in the treatment of PD. After the initial cognitive and laboratory testing, the first infusion appointment will be planned within 2 weeks. …
Sponsor: Fatima Jinnah Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
A pharmacist's quick check on inhaler costs and guidelines may keep COPD and asthma patients out of the hospital
Disease control CompletedThe goal of this study is to assess the impact of pharmacist-led benefits investigations and application of clinical practice guidelines on patient access to inhalers and time to hospital readmission or Emergency Department (ED) visit.
Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Spinal implant aims to stabilize the back and ease pain
Disease control CompletedA 2 and 5 year evaluation of clinical outcomes in the treatment of degenerative spinal stenosis with concomitant low back pain by decompression with additional stabilization using the coflex® Interlaminar Technology for FDA Actual Conditions of Use Study.
Sponsor: Companion Spine, LLC • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New combo attack on returning prostate cancer shows promise
Disease control CompletedThis phase II trial studies how well surgery and radiation therapy work in treating patients with prostate cancer that has come back or spread to other parts of the body. Radiation therapy uses high energy beams to kill tumor cells and shrink tumors. Surgical procedures, such as …
Phase 2 • Sponsor: University of Utah • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New hope for liver cancer patients: cabozantinib safety trial shows promise
Disease control CompletedHepatocellular carcinoma (HCC) is a common tumor (the 8th leading cause of cancer in France) and has a poor prognosis. It is the 3rd leading cause of cancer deaths in the world. In the early stages (low tumor mass), HCC can be treated for curative purposes by surgical resection, …
Phase 4 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Blood cancer drug venetoclax gets Long-Term safety check
Disease control OngoingThe purpose of this extension study is to provide venetoclax and obtain long-term safety data for subjects who continue to tolerate and derive benefit from receiving venetoclax in ongoing studies.
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Could a lower warfarin dose cut bleeding risk in valve patients?
Disease control Recruiting nowThis study evaluates the use of a lower INR target (1.5 to 2.5) in patients with a mechanical bileaflet heart valve in the aortic position. This study will inform physicians about whether a lower INR target will decrease the risk of bleeding or increase the risk of blood clot for…
Phase 3 • Sponsor: Population Health Research Institute • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC